Immuron Travelan® sales continued strong growth
10 avr. 2024 06h00 HE
|
Immuron Limited
Sales Highlights: Global FYTD Mar 2024 AUD$3.6 million up 154% on (prior comparative period) pcpMar 2024 Quarter AUD$1.3 million up 51% on pcp and 75% on last quarter ...
Immuron Q3 Sales reach 150% of 1H Sales
06 avr. 2023 06h00 HE
|
Immuron Limited
Highlights: Australian Q3 FY23 sales of A$577 k (201% of 1H sales)North American Q3 FY23 Travelan® sales of A$298 k (100% of 1H sales)Global Q3 YTD FY23 sales of A$1.46 M represent an increase of...
Immuron North American Travelan® Sales up 494% and Global sales up 431%
11 juil. 2022 06h00 HE
|
Immuron Limited
Highlights: North American FY22 Travelan® sales increased by +494% to $0.6MGlobal sales increased by 431% to $0.9MAustralian FY22 sales increased by 318% to $0.3M MELBOURNE, Australia, July 11,...
Immuron Travelan® Global sales up 216%
27 avr. 2022 06h00 HE
|
Immuron Limited
Key Highlights: North American Travelan® sales up by 185% YoY in Q3 FY22Global sales up 216% YoY in Q3 FY22.YTD March 31, FY22 worldwide Travelan® sales reached AU $392K, increasing 340% YoY. ...
Immuron North American revenue surges by 52% in FY19
16 juil. 2019 06h00 HE
|
Immuron Limited
Key Highlights: Immuron FY19 revenue surged by 52% in North America, reaching $1.16M.In the USA, FY19 Travelan® sales exceeded the $1M AUD milestone for the first time and grew by +32% to $1.02M AUD....
NASH clinical trial presentation and continued revenue growth
09 nov. 2018 06h00 HE
|
Immuron Limited
Key Highlights: Professor Arun Sanyal to present IMM-124E NASH clinical trial results at the Liver Meeting in San FranciscoTravelan® on display at HealthEdAustralian Travelan® sales continue to...
Travelan Experiences Strong Q1 FY2018 Sales Growth
08 nov. 2017 09h00 HE
|
Immuron Limited
Key Highlights: Significant growth of sales for Immuron’s over-the-counter supplement Travelan® for Q1 2018 compared to Q1 2017 Travelan® US experienced a 197% increase in sales compared to Q1...